Modified-release subantimicrobial dose doxycycline enhances scaling and root planing in subjects with periodontal disease

Journal of Periodontology

Volumn 79, Issue 3, 2008, Pages 440-452

  Preshaw, Philip M ^a   Novak, M John ^b   Mellonig, James ^c   Magnusson, Ingvar ^d   Polson, Alan ^e   Giannobile, William V ^f   Rowland, Randal W ^g   Thomas, John ^h   Walker, Clay ^d   Dawson, Dolphus R ^b   Sharkey, Dennis ^e   Bradshaw, Mark H ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF KENTUCKY   (United States)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^d UNIVERSITY OF FLORIDA   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f UNIVERSITY OF MICHIGAN   (United States)

^g West Virginia University ^*

^h Global Consulting Partners in Medical Biometrics   (United States)

Author keywords

Double masked method; Doxycycline therapeutic use; Multicenter; Periodontitis drug therapy

Indexed keywords

ANTIINFECTIVE AGENT; DOXYCYCLINE;

ADULT; AGED; ANAEROBIC BACTERIUM; ANALYSIS OF VARIANCE; ARTICLE; BACTERIAL COUNT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; MIDDLE AGED; MULTICENTER STUDY; MULTIMODALITY CANCER THERAPY; NONPARAMETRIC TEST; PERIODONTICS; PERIODONTITIS; PREVENTIVE DENTISTRY; RANDOMIZED CONTROLLED TRIAL; STATISTICAL MODEL; TOOTH PLAQUE; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANTI-BACTERIAL AGENTS; BACTERIA, ANAEROBIC; COLONY COUNT, MICROBIAL; COMBINED MODALITY THERAPY; DENTAL PLAQUE; DENTAL SCALING; DOUBLE-BLIND METHOD; DOXYCYCLINE; FEMALE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; PERIODONTAL INDEX; PERIODONTITIS; STATISTICS, NONPARAMETRIC;

EID: 41449105532     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2008.070375     Document Type: Article

References (31)

1. Caton JG, Ciancio SG, Blieden TM, et al. Treatment with subantimicrobial dose doxycycline improves the efficacy of scaling and root planing in patients with adult periodontitis. J Periodontol 2000;71:521-532.
2. Caton JG, Ciancio SG, Blieden TM, et al. Subantimicrobial dose doxycycline as an adjunct to scaling and root planing: Post-treatment effects. J Clin Periodontol 2001;28:782-789.
3. Novak MJ, Johns LP, Miller RC, Bradshaw MH. Adjunctive benefits of subantimicrobial dose doxycycline in the management of severe, generalized, chronic periodontitis. J Periodontol 2002;73:762-769.
4. Emingil G, Atilla G, Sorsa T, Luoto H, Kirilmaz L, Baylas H. The effect of adjunctive low-dose doxycycline therapy on clinical parameters and gingival crevicular fluid matrix metalloproteinase-8 levels in chronic periodontitis. J Periodontol 2004;75:106-115.
5. Preshaw PM, Hefti AF, Novak MJ, et al. Subantimicrobial dose doxycycline enhances the efficacy of scaling and root planing in chronic periodontitis: A multicenter trial. J Periodontol 2004;75:1068-1076.
6. Walker C, Thomas J, Nango S, Lennon J, Wetzel J, Powala C. Long-term treatment with subantimicrobial dose doxycycline exerts no antibacterial effect on the subgingival microflora associated with adult periodontitis. J Periodontol 2000;71:1465-1471.
7. Skidmore R, Kovach R, Walker C, et al. Effects of subantimicrobial-dose doxycycline in the treatment of moderate acne. Arch Dermatol 2003;139:459-464.
8. Walker C, Preshaw PM, Novak J, Hefti AF, Bradshaw M, Powala C. Long-term treatment with sub-antimicrobial dose doxycycline has no antibacterial effect on intestinal flora. J Clin Periodontol 2005;32:1163-1169.
9. Golub LM, Sorsa T, Lee HM, et al. Doxycycline inhibits neutrophil (PMN)-type matrix metalloproteinases in human adult periodontitis gingiva. J Clin Periodontol 1995;22:100-109.
10. Romanelli R, Mancini S, Laschinger C, Overall CM, Sodek J, McCulloch CA. Activation of neutrophil collagenase in periodontitis. Infect Immun 1999;67:2319-2326.
11. Choi DH, Moon IS, Choi BK, et al. Effects of subantimicrobial dose doxycycline therapy on crevicular fluid MMP-8, and gingival tissue MMP-9, TIMP-I and IL-6 levels in chronic periodontitis. J Periodontal Res 2004;39:20-26.
12. Golub LM, Lee HM, Greenwald RA, et al. A matrix metalloproteinase inhibitor reduces bone-type collagen degradation fragments and specific collagenases in gingival crevicular fluid during adult periodontitis. Inflamm Res 1997;46:310-319.
13. Gapski R, Barr JL, Sarment DP, Layher MG, Socransky SS, Giannobile WV. Effect of systemic matrix metalloproteinase inhibition on periodontal wound repair:A proof of concept trial. J Periodontol 2004;75: 441-452.
14. Brown DL, Desai KK, Vakili BA, Nouneh C, Lee HM, Golub LM. Clinical and biochemical results of the metalloproteinase inhibition with subantimicrobial doses of doxycycline to prevent acute coronary syndromes (MIDAS) pilot trial. Arterioscler Thromb Vasc Biol 2004;24:733-738.
15. O'Dell JR, Elliott JR, Mallek JA, et al. Treatment of early seropositive rheumatoid arthritis: Doxycycline plus methotrexate versus methotrexate alone. Arthritis Rheum 2006;54:621-627.
16. Bikowski JB. Subantimicrobial dose doxycycline for acne and rosacea. Skinmed 2003;2:234-245.
17. Jordan TJ, Reichman LB. Once-daily versus twice-daily dosing of theophylline. A decision analysis approach to evaluating theophylline blood levels and compliance. Am Rev Respir Dis 1989;140:1573-1577.
18. Andrejak M, Genes N, Vaur L, Poncelet P, Clerson P, Carre A. Electronic pill-boxes in the evaluation of antihypertensive treatment compliance: Comparison of once daily versus twice daily regimen. Am J Hypertens 2000;13:184-190.
19. Simon JA, Lewiecki EM, Smith ME, Petruschke RA, Wang L, Palmisano JJ. Patient preference for onceweekly alendronate 70 mg versus once-daily alendronate 10 mg: A multicenter, randomized, open-label, crossover study. Clin Ther 2002;24:1871-1886.
20. Poison AM, Southard GL, Dunn RL, Poison AP, Billen JR, Laster LL. Initial study of guided tissue regeneration in Class II furcation defects after use of a biodegradable barrier. Int J Periodontics Restorative Dent 1995;15:42-55.
21. Cobb CM. Clinical significance of non-surgical periodontal therapy: An evidence-based perspective of scaling and root planing. J Clin Periodontol 2002;29 (Suppl. 2):6-16.
22. Walker C, Sedlaeek MJ. An in vitro biofilm model of subgingival plaque. Oral Microbiol Immun 2007;22: 152-161.
23. Thomas J, Walker C, Bradshaw M. Long-term use of subantimicrobial dose doxycycline does not lead to changes in antimicrobial susceptibility. J Periodontol 2000;71:1472-1483.
24. Preshaw PM, Hefti AF, Bradshaw MH. Adjunctive subantimicrobial dose doxycycline in smokers and non-smokers with chronic periodontitis. J Clin Periodontol 2005;32:610-616.
25. Mohammad AR, Preshaw PM, Bradshaw MH, Hefti AF, Powala CV, Romanowicz M. Adjunctive subantimicrobial dose doxycycline in the management of institutionalised geriatric patients with chronic periodontitis. Gerodontology 2005;22:37-43.
26. Armitage GC. Development of a classification system for periodontal diseases and conditions. Ann Periodontol 1999;4:1-6.
27. Cobb CM. Non-surgical pocket therapy: Mechanical. Ann Periodontol 1996;1:443-490.
28. Lang NP, Nyman S, Adler R, Joss A. Absence of bleeding on probing - A predictor for periodontal health. J Clin Periodontol 1990;17:714-721.
29. Caton JG. Evaluation of Periostat for patient management. Compend Contin Educ Dent 1999;20:451-456.
30. Walker CB, Karpinia K, Baehni P. Chemotherapeutics: Antibiotics and other antimicrobials. Periodontol 2000 2004;36:146-165.
31. Thomas JG, Metheny RJ, Karakiozis JM, Wetzel JM, Crout RJ. Long-term sub-antimicrobial doxycycline (Periostat) as adjunctive management in adult periodontitis: Effects on subgingival bacterial population dynamics. Adv Dent Res 1998;12:32-39.